VECTOCELL

USPTO USPTO 2001 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke VECTOCELL wurde als Wortmarke am 31.01.2001 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 04.05.2004 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 17. Mai 2018

Markenform Wortmarke
Aktenzeichen 76203215
Registernummer 2837634
Anmeldedatum 31. Januar 2001
Veröffentlichungsdatum 03. Juni 2003
Eintragungsdatum 04. Mai 2004

Markeninhaber

166, Boulevard du Montparnasse
75014 Paris
FR

Markenvertreter

Waren und Dienstleistungen

1 Chemical, biochemical, biological, biotechnological products and preparations, namely nucleic acids, proteins, antibiotics, antiviral molecules and immunomodulators, intended for the pharmaceutical industry and for sciences, other than for medical or veterinary use; chemical, biochemical, biological, biotechnological products, namely nucleic acids, proteins, antibiotics, antiviral molecules and immunomodulators for laboratory analyses, other than for medical or veterinary use; biochemical namely, precursors for in vitro genetic engineering use; diagnostic preparations for scientific or research use, namely, cell lines, diagnosis kits, comprised of cell penetrating peptides conjugated to antibodies against intracellular and intranuclear markers or antigens; labeling kits, comprised of cell penetrating peptides tagged with markers for intracellular and intranuclear labeling of targets; expression kits, comprised of cell penetrating peptides acting as transfection or gene transfer agents; development kits, comprised of cell penetrating peptides for intracellular and intranuclear delivery of drug candidates for drug screening purposes; and target validation kits comprised of cell penetrating peptides coupled with drug candidates or markers for intracellular and intranuclear target validation; chemical reagents for scientific and research use
5 Pharmaceutical preparations for the treatment of viral, bacterial, fungal and parasitic infections; cancer; degenerative diseases; metabolic and endocrine diseases; cardiovascular diseases; inflammatory diseases; autoimmune diseases; and dermatological diseases; veterinary vaccines for small, large and exotic animals; chemopharmaceutical preparations for use in chemotherapy; media for bacteriological and bacterial cultures for medical and veterinary use; diagnostic preparations for clinical or medical laboratory use
42 Technical consultation and research in biology, in plant and animal biotechnology, pharmacology, biology, biotechnology, pharmacy, and medicine; providing information in the fields of biology, biotechnology, pharmacy, and medicine; research and development of new products for others in the fields of pharmacy, biology and biotechnology, medicine and the sciences; laboratory research in the fields of biology, biotechnology, pharmacy, and medicine and the sciences; genetic engineering in the fields of pharmacology, medicine, the sciences
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376203215